4/11/2025YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...

4/10/2025Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...

4/10/2025Trump's Planned Tariffs on Imported Pharmaceuticals Target China

4/9/2025BioDuro Expands China Operations with New R&D and Manufacturing Campus...

4/9/2025U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...

4/8/2025China Approves Hansoh's Ibrexafungerp for Vaginal Yeast Infections

4/8/2025Duality Bio Upsizes IPO Amid Global Market Challenges

4/8/2025Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...

4/8/2025Tariffs Spark Market Jitters, But China's Innovative Drug Sector Remai...

4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...

4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China

4/8/2025Rigerna Thera Advances siRNA Drug Development with Pre-A Financing​

4/7/2025Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...

4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations

4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...

4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy

4/5/2025Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...

4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...

4/1/2025Vivace Thera Raises $35M in Series D Financing

3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib

3/31/2025Bio-Thera and Dr. Reddy's Execute Commercialization Deal for BAT2206 a...

3/31/2025Vcare PharmaTech Secures Series C+ Financing and Advances Clinical Pip...

3/28/2025DualityBio Advances Toward Hong Kong Stock Exchange Listing

3/28/2025Eisai to Divest China Rights for Pariet® to Peak Pharma

3/27/2025China Faces Ongoing TB Prevention Challenges Despite Declining Inciden...

3/27/2025China Poised to Surpass Europe in Pharma Innovation, Says AZ CEO

3/26/2025Bayer Secures Global Rights to Puhe BioPharma's Experimental Cancer Dr...

3/26/2025Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346

3/25/2025Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...

3/25/2025Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...

Page:1/20 Total number of articles:593: [First][<<] [1] [2] [3] [4] [5] [>>] [End]